Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Sep 9, 2016 · 10-K · 71 days after period end · 0001144204-16-123313
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.12M | $1.34M | $949.52K | $1.24M |
| Net Income | -$1.19M | -$1.03M | -$1.68M | -$993.56K |
| EPS Diluted | -$0.02 | -$0.02 | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Sep 9, 2016 · 71 d after period end
